DESCRIPTION:
Xolamol is the combination of a topical carbonic anhydrase inhibitor and a topical beta-adrenergic receptor blocking agent.
INDICATIONS AND USAGE:
Xolamol is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target IOP determined after multiple measurements over time).
HOW SUPPLIED:
Xolamol Sterile Ophthalmic Solution, 5 ml in LDPE bottles.